How is the InflaRx N.V. today?

The InflaRx N.V. today is trading in the down by -6.74% at 1.66.

What is InflaRx N.V. Annual Revenue?

InflaRx N.V. Annual Revenue rose 162.78%, in the last year to $0.17 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is InflaRx N.V. Annual Net Profit?

InflaRx N.V. Annual Net Profit fell 7.96% in the last year to $46.06 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is InflaRx N.V. Price to Earning Ratio?

InflaRx N.V. Price to Earning Ratio is -2.25, which is negative.

What is InflaRx N.V. Stock Price?

InflaRx N.V. Stock Price rose 14.48% and outperformed its sector by 5.62% in the past year.

What is InflaRx N.V. Quarterly Net profit?

InflaRx N.V. Quarterly Net profit rose 13.91% YoY to $8.31 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is InflaRx N.V. Debt to Equity Ratio?

InflaRx N.V. Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is InflaRx N.V. Return on Equity(ROE)?

InflaRx N.V. Return on Equity(ROE) for the last financial year was -56.18%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is InflaRx N.V. Mutual Fund Holding?

InflaRx N.V. Mutual Fund Holding increased by 0.02% in the last quarter to 0.17.

What is InflaRx N.V. Interest Coverage Ratio?

InflaRx N.V. Interest Coverage Ratio is -2228.93, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is InflaRx N.V. Institutional Holding?

InflaRx N.V. Institutional Holding decreased by 0% in the last quarter to 19.22.

InflaRx N.V. XNAS: IFRX

InflaRx N.V. Live Share Price Today, Share Analysis and Chart

Name: InflaRx N.V.: Is Infosys Ltd. worth buying?
Item: InflaRx N.V.
Rating: 1.42241675
Author: Trendlyne DVM scores

about

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its recepto...

1.66 -0.12 (-6.74%)

41.13% Fall from 52W High

237.4K XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

0.7 / 100

Technically Neutral

56.2 / 100

9

1Yr Price target upside is 430%

7 analysts

InflaRx N.V. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

InflaRx N.V. FAQ

How is InflaRx N.V. today?

InflaRx N.V. today is trading in the red, and is down by -6.74% at 1.66.

How has InflaRx N.V. performed historically?

InflaRx N.V. is currently trading down -6.74% on an intraday basis. In the past week the stock rose 3.11%. stock has been down -17.00% in the past quarter and rose 14.48% in the past year. You can view this in the overview section.